优秀论文交流 IV
Paper Oral Presentation IV
04/18 15:40-17:40
优秀论文交流区 (Oral Presentation Area)
-
15:40-17:40
-
15:40-15:50应用Prizvalve行经导管二尖瓣置换术治疗风湿性二尖瓣狭窄的初步经验Preliminary Experience of Transcatheter Mitral Valve Replacement with Prizvalve for Rheumatic Mitral Stenosis
-
15:50-16:00ADAMTS-5作为钙化性主动脉瓣疾病新型血清生物标志物的价值研究Value of ADAMTS-5 as a Novel Serum Biomarker for Calcific Aortic Valve Disease
-
16:00-16:10炎症 - 胰岛素抵抗指标与钙化性主动脉瓣狭窄患者全因及心血管死亡率的相关性：ARISTOTLE 队列研究Association Between Inflammation-insulin Resistance Indicator and All-cause and Cardiovascular Mortality in Patients with Calcific Aortic Valve Stenosis: The ARISTOTLE Cohort Study
-
16:10-16:20生物瓣膜毁损后的瓣中瓣经导管置换术与再次外科主动脉瓣置换术的围术期恢复及血流动力学性能比较：一项回顾性队列研究Perioperative Recovery and Hemodynamic Performance of Valve-in-Valve Transcatheter Versus Redo Surgical Aortic Valve Replacement for Degenerated Bioprostheses: A Retrospective Cohort Study
-
16:20-16:30室间隔厚度对单纯主动脉瓣反流患者TAVR术后新发传导阻滞的预测价值分析Predictive Value of Interventricular Septal Thickness for New-Onset Conduction Block After TAVR in Patients with Pure Aortic Regurgitation
-
16:30-16:40重度主动脉瓣狭窄合并急性失代偿性心力衰竭患者应用主动脉内球囊反搏支持的可行性与结局分析Feasibility and Outcome Analysis of Intra-Aortic Balloon Pump Support in Severe Aortic Stenosis Patients with Acute Decompensated Heart Failure
-
16:40-16:50短支架、自膨胀、可完全回收的TAVR器械治疗纯主动脉瓣反流的操作性能及30天结果Short-frame, Self-expanding, Fully Recapturable TAVR Device in Pure Aortic Regurgitation: Procedural Performance and 30-day Outcomes
-
16:50-17:00低密度脂蛋白胆固醇与中重度三尖瓣反流全因死亡率的U型关联：一项回顾性队列研究U-Shaped Association Between Low-Density Lipoprotein Cholesterol and All-Cause Mortality in Moderate to Severe Tricuspid Regurgitation: A Retrospective Cohort Study
-
17:00-17:10合并症状性主动脉瓣狭窄与射血分数保留的心力衰竭 (HFpEF) 患者TAVR术后心衰再住院的预后列线图开发与验证：一项多中心研究Development and Validation of a Prognostic Nomogram for Post-TAVR Heart Failure Hospitalization in Patients with Concurrent Symptomatic Aortic Stenosis and HFpEF: A Multicenter Study
-
17:10-17:40讨论Discussion